checkAd
    Startseite > Aktien > Spexis > Nachrichten
    Spexis Aktie
    0,0600
     
    EUR
    0,00 %
    0,0000 EUR
    Letzter Kurs 09:50:12 Lang & Schwarz
    0,0472
     
    EUR
    146.843 STK
    Geldkurs 09:50:12
    0,0728
     
    EUR
    146.843 STK
    Briefkurs 09:50:12
    ISIN: CH0106213793 · WKN: A2JK4Q · Schweiz

    Neueste Nachrichten

    Spexis Gets 2nd Extension for 2023 Report, Unveils Financials & SPRIM Dispute Update
    31.05.24 · wO Newsflash · Spexis
    Spexis receives second extension for the publication of its 2023 annual report until July 31, 2024, releasing its unaudited financial statements and providing an update on its dispute with SPRIM.
    31.05.24 · EQS Group AG · Spexis
    Spexis receives approval of an extension of the deadline for the publication of its 2023 annual report and audited financials until latest May 31, 2024. 
    30.04.24 · EQS Group AG · Spexis
    Spexis announces extension of moratorium, receipt of an additional payment related to the sale of a preclinical antibiotics program and reversion of the lonodelestat license from Santhera
    17.04.24 · EQS Group AG · Spexis
    Spexis announces closing of sale of preclinical antibiotics program to Basilea
    08.02.24 · EQS Group AG · Spexis
    Spexis announces sale of preclinical antibiotics program to Basilea
    15.01.24 · EQS Group AG · Spexis
    Spexis Secures Debt-Restructuring Moratorium: A New Chapter Begins
    05.12.23 · wO Newsflash · Spexis
    Spexis is Granted Debt-Restructuring Moratorium
    05.12.23 · EQS Group AG · Spexis
    Spexis Announces Latest Developments on Debt-Restructuring Moratorium
    29.11.23 · wO Newsflash · Spexis
    Spexis Provides Update Regarding Debt-Restructuring Moratorium
    29.11.23 · EQS Group AG · Spexis
    Spexis Seeks Debt-Restructuring Moratorium: A Bold Move in Financial Strategy
    08.11.23 · wO Newsflash · Spexis
    Spexis to file an application for a debt-restructuring moratorium
    08.11.23 · EQS Group AG · Spexis

    Ad-hoc Nachrichten

    Spexis Gets 2nd Extension for 2023 Report, Unveils Financials & SPRIM Dispute Update
    31.05.24 · wO Newsflash · Spexis
    Spexis receives second extension for the publication of its 2023 annual report until July 31, 2024, releasing its unaudited financial statements and providing an update on its dispute with SPRIM.
    31.05.24 · EQS Group AG · Spexis
    Spexis receives approval of an extension of the deadline for the publication of its 2023 annual report and audited financials until latest May 31, 2024. 
    30.04.24 · EQS Group AG · Spexis
    Spexis announces extension of moratorium, receipt of an additional payment related to the sale of a preclinical antibiotics program and reversion of the lonodelestat license from Santhera
    17.04.24 · EQS Group AG · Spexis